GW&K Investment Management LLC boosted its position in shares of Exponent Inc. (NASDAQ:EXPO) by 17.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 316,076 shares of the company’s stock after buying an additional 46,418 shares during the period. GW&K Investment Management LLC’s holdings in Exponent were worth $18,462,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Jacobs Levy Equity Management Inc. raised its position in shares of Exponent by 5.8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 5,630 shares of the company’s stock worth $287,000 after buying an additional 310 shares during the last quarter. BlackRock Inc. raised its position in shares of Exponent by 18.4% in the first quarter. BlackRock Inc. now owns 6,498 shares of the company’s stock worth $332,000 after buying an additional 1,008 shares during the last quarter. Aperio Group LLC raised its position in shares of Exponent by 15.1% in the first quarter. Aperio Group LLC now owns 7,084 shares of the company’s stock worth $361,000 after buying an additional 932 shares during the last quarter. 1st Global Advisors Inc. raised its position in shares of Exponent by 78.8% in the second quarter. 1st Global Advisors Inc. now owns 7,946 shares of the company’s stock worth $464,000 after buying an additional 3,501 shares during the last quarter. Finally, BNP Paribas Arbitrage SA raised its position in shares of Exponent by 112.1% in the second quarter. BNP Paribas Arbitrage SA now owns 8,178 shares of the company’s stock worth $478,000 after buying an additional 4,322 shares during the last quarter. Institutional investors and hedge funds own 91.46% of the company’s stock.
Exponent Inc. (NASDAQ:EXPO) traded up 0.71% on Wednesday, reaching $50.79. The company’s stock had a trading volume of 44,183 shares. The company has a 50-day moving average price of $50.36 and a 200 day moving average price of $51.90. Exponent Inc. has a 12 month low of $44.11 and a 12 month high of $59.71. The company has a market cap of $1.32 billion, a P/E ratio of 29.02 and a beta of 0.81.
Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Tuesday, July 19th. The company reported $0.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by $0.05. The firm earned $77.30 million during the quarter, compared to the consensus estimate of $80.46 million. Exponent had a net margin of 15.13% and a return on equity of 16.02%. On average, equities research analysts anticipate that Exponent Inc. will post $1.59 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, September 23rd. Stockholders of record on Friday, September 2nd were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Wednesday, August 31st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.42%. Exponent’s payout ratio is 41.62%.
A number of brokerages recently commented on EXPO. Zacks Investment Research lowered Exponent from a “hold” rating to a “strong sell” rating in a research note on Friday, July 22nd. Avondale Partners began coverage on Exponent in a research note on Thursday, July 7th. They issued a “market perform” rating and a $60.00 target price for the company. Finally, Cantor Fitzgerald began coverage on Exponent in a research note on Friday, August 26th. They issued a “buy” rating and a $57.00 target price for the company.
In other news, insider Paul Boehm sold 5,000 shares of the company’s stock in a transaction on Tuesday, August 16th. The stock was sold at an average price of $52.18, for a total transaction of $260,900.00. Following the completion of the sale, the insider now directly owns 24,045 shares in the company, valued at approximately $1,254,668.10. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Paul R. Johnston sold 5,578 shares of the company’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $58.15, for a total value of $324,360.70. Following the sale, the chief executive officer now owns 64,458 shares of the company’s stock, valued at $3,748,232.70. The disclosure for this sale can be found here. Insiders own 3.50% of the company’s stock.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.